Cardiotoxic effect with convulsions in terfenadine overdose.
作者信息
Davies A J, Harindra V, McEwan A, Ghose R R
机构信息
Singleton Hospital, Swansea.
出版信息
BMJ. 1989 Feb 4;298(6669):325. doi: 10.1136/bmj.298.6669.325.
Abstract
摘要
相似文献
1
Cardiotoxic effect with convulsions in terfenadine overdose.特非那定过量导致的伴有惊厥的心脏毒性作用。
BMJ. 1989 Feb 4;298(6669):325. doi: 10.1136/bmj.298.6669.325.
2
[Severe antihistamine poisoning complicated by ventricular tachycardia].[严重抗组胺药中毒并发室性心动过速]
Vnitr Lek. 1990 Mar;36(3):266-9.
3
4
Cardiotoxicity of histamine and the possible role of histamine in the arrhythmogenesis produced by certain antihistamines.组胺的心脏毒性以及组胺在某些抗组胺药所致心律失常发生过程中的可能作用。
Drug Saf. 1999;21 Suppl 1:33-8; discussion 81-7. doi: 10.2165/00002018-199921001-00005.
5
Comparison of the onset of H1-antagonism with acrivastine and terfenadine by histamine bronchial challenge in volunteers.在志愿者中通过组胺支气管激发试验比较阿伐斯汀和特非那定的H1拮抗作用起效情况。
J Int Med Res. 1989;17 Suppl 2:35B-39B.
6
[Terfenadine--cardiac adverse effects].[特非那定——心脏不良反应]
Lakartidningen. 1991 May 22;88(21):1999-2000.
7
8
Torsades de pointes occurring in association with terfenadine use.与使用特非那定相关的尖端扭转型室性心动过速。
JAMA. 1990 Dec 5;264(21):2788-90.
9
Dangers of non-sedating antihistamines.
Lancet. 1997 May 3;349(9061):1268. doi: 10.1016/S0140-6736(05)62504-4.
10
Drug interactions associated with terfenadine and related nonsedating antihistamines.与特非那定及相关非镇静性抗组胺药相关的药物相互作用。
West J Med. 1996 Jan;164(1):68-9.
引用本文的文献
1
Acquired long QT syndrome and phosphoinositide 3-kinase.获得性长QT综合征与磷酸肌醇3激酶
Trends Cardiovasc Med. 2017 Oct;27(7):451-459. doi: 10.1016/j.tcm.2017.05.005. Epub 2017 May 17.
2
Drug-drug interactions and QT prolongation as a commonly assessed cardiac effect - comprehensive overview of clinical trials.药物相互作用和QT间期延长作为一种常见的心脏效应评估——临床试验综述
BMC Pharmacol Toxicol. 2016 Mar 10;17:12. doi: 10.1186/s40360-016-0053-1.
3
Cardiovascular safety of antihistamines.抗组胺药的心血管安全性。
Postepy Dermatol Alergol. 2014 Jun;31(3):182-6. doi: 10.5114/pdia.2014.43191. Epub 2014 Jun 13.
4
Drug-induced arrhythmia: pharmacogenomic prescribing?药物诱导的心律失常：药物基因组学处方？
Eur Heart J. 2013 Jan;34(2):89-95. doi: 10.1093/eurheartj/ehs351. Epub 2012 Oct 22.
5
Examining the utilization and tolerability of the non-sedating antihistamine levocetirizine in England using prescription-event monitoring data.利用处方事件监测数据考察在英格兰使用非镇静抗组胺药左西替利嗪的使用情况和耐受性。
Drug Saf. 2011 Dec 1;34(12):1177-89. doi: 10.2165/11593930-000000000-00000.
6
Drug-induced long QT syndrome.药物性长 QT 综合征。
Pharmacol Rev. 2010 Dec;62(4):760-81. doi: 10.1124/pr.110.003723.
7
Treatment of allergic rhinitis in infants and children: efficacy and safety of second-generation antihistamines and the leukotriene receptor antagonist montelukast.婴幼儿变应性鼻炎的治疗：第二代抗组胺药和白三烯受体拮抗剂孟鲁司特的疗效和安全性。
Drugs. 2009;69(18):2541-76. doi: 10.2165/9884960-000000000-00000.
8
Examining the tolerability of the non-sedating antihistamine desloratadine: a prescription-event monitoring study in England.考察非镇静性抗组胺药地氯雷他定的耐受性：一项在英国开展的处方事件监测研究。
Drug Saf. 2009;32(2):169-79. doi: 10.2165/00002018-200932020-00009.
9
Cellular basis of drug-induced torsades de pointes.药物诱导的尖端扭转型室性心动过速的细胞基础。
Br J Pharmacol. 2008 Aug;154(7):1502-7. doi: 10.1038/bjp.2008.238. Epub 2008 Jun 16.
10
Drug-induced cardiovascular disorders.药物性心血管疾病
Drug Saf. 2007;30(9):783-804. doi: 10.2165/00002018-200730090-00005.
本文引用的文献
1
Bioavailability of terfenadine in man.
Biopharm Drug Dispos. 1981 Apr-Jun;2(2):185-90. doi: 10.1002/bdd.2510020211.
Zotero 插件